Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Alexandra C. Walls(BioNTech (United States)), David Veesler(Howard Hughes Medical Institute), Jason S. McLellan(The University of Texas at Austin), Marcos C. Miranda(University of Washington), Robbert van der Most(GlaxoSmithKline (Belgium)), Wesley C. Van Voorhis(Joint Center for Structural Genomics), M. Alejandra Tortorici(University of Washington), Elizabeth Kepl(University of Washington), Max Johnson(University of Washington), Tyler N. Starr(University of Utah), David R. Martinez(University of North Carolina at Chapel Hill), Roland Tisch(University of North Carolina at Chapel Hill), Brooke Fiala(University of Washington), Neil P. King(University of Washington), Ralph S. Baric(University of North Carolina at Chapel Hill), Samuel Wrenn(University of Washington), Lauren Carter(University of Washington), Kelly D. Smith(University of Washington), Douglas E. Ferrell(University of Louisiana at Lafayette), Kaitlin R. Sprouse(University of Washington), Rashmi Ravichandran(University of Washington), Deleah Pettie(University of Washington), Kenneth A. Rogers(University of Louisiana at Lafayette), Sasha W. Tilles(University of Washington), Bali Pulendran(Palo Alto University), John E. Bowen(University of Washington), François Villinger(The University of Texas MD Anderson Cancer Center), Prabhu S. Arunachalam(Stanford University), Alyssa Blackstone(University of Washington), Matthew Clark(University of Nottingham), Natalie Brunette(University of Washington), Sarah R. Leist(University of North Carolina at Chapel Hill), Harry Kleanthous(Gates Foundation), Minh N. Pham(University of Washington), Lisa Shirreff(University of Louisiana at Lafayette), Cassandra Ogohara(University of Washington), Samantha K. Zepeda(University of Washington), Megan A. O’Connor(University of Washington), Deborah H. Fuller(WSP (Canada)), Allison J. Greaney(University of Washington), Claire Sydeman(University of Washington), Rino Rappuoli(University of Siena), Mary-Jane Navarro(University of Washington), Jesse D. Bloom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ching‐Lin Hsieh(Asia University), Derek T. O’Hagan(GlaxoSmithKline (United States)), Timothy P. Sheahan(University of North Carolina at Chapel Hill), Alexandra Schäfer(University of North Carolina at Chapel Hill), Davide Corti(Vir Biotechnology (Switzerland))
Cited by 192
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
<i>cag</i> , a pathogenicity island of <i>Helicobacter pylori,</i> encodes type I-specific and disease-associated virulence factors
|Proceedings of the National Academy of Sciences|1996|1.9k
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
|Nature Communications|2020|1.8k
Site-specific glycan analysis of the SARS-CoV-2 spike
|Science|2020|1.7k